Study summary

The purpose of this study is to evaluate the impact of Advagraf, prolonged-release, once daily tacrolimus formulation, on long-term graft survival in kidney and liver allograft recipients. This study will also evaluate the overall long-term impact of Advagraf on kidney and liver allograft recipients.

Additional Study Details

Phase
N/A
Product
N/A
Product
Tacrolimus
Type
Observational
Masking
N/A
Enrollment number
2300
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A 5 year follow-up of patients who were previously enrolled into an Advagraf trial following a liver or kidney transplant? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Site SK42101
    Banska Bystrica, Slovakia, 975 01
    Completed
    Site IT39013
    Bologna, Italy, 40138
    Completed
    Site DE49018
    Hannover, Germany, 30625
    Completed
    Site FR33026
    Le Kremlin Bicetre, France, 94275
    Completed
    Site DE49006
    Tubingen, Germany, 72076
    Completed
    Site RU70004
    Moscow, Russian Federation, 129090
    Completed
    Site FR33027
    Clermont-Ferrand, France, 63003
    Completed
    Site PL48004
    Szczecin, Poland, 70-111
    Completed
    Site ES34014
    Sevilla, Spain, 41013
    Completed
    Site HU36002
    Szeged, Hungary, 6720
    Completed
    Site FR33024
    Rouen Cedex, France, 76233
    Completed
    Site FR33008
    Paris, France, 75571
    Completed
    Site CZ42004
    Hradec Kralove, Czech Republic, 500 05
    Completed
    Site SE46002
    Stockholm, Sweden, 14186
    Withdrawn
    Site LT37001
    Vilnius, Lithuania, LT-08661
    Completed
    Site SK42102
    Bratislava, Slovakia, 833 05
    Completed
    Site FR33032
    Dijon, France, 21079
    Completed
    Site LV37101
    Riga, Latvia, LV-1002
    Completed
    Site RU70011
    Volzhskiy, Russian Federation, 404120
    Completed
    Site PL48005
    Lodz, Poland, 91-153
    Completed
    Site BE32009
    Liege, Belgium, 4000
    Completed
    Site RO40003
    Bucharest, Romania, 22328
    Completed
    Site FR33003
    Clichy, Paris, France, 92118
    Completed
    Site FR33031
    Paris Cedex 15, France, 75743
    Completed
    Site FR33001
    Creteil, France, 94000
    Completed
    Site CA15003
    Montreal, QC, Canada, H2X3J4
    Completed
    Site SE46001
    Gothenburg, Sweden, 41345
    Completed
    Site DE49027
    Mannheim, Germany, 68167
    Completed
    Site ES34004
    Barcelona, Spain, 08035
    Completed
    Site DE49019
    Bochum, Germany, 44892
    Completed
    Site ES34001
    Hospitalet de Llobregat, Barcelona, Spain, 08907
    Completed
    Site RU70013
    Volzhskiy, Russian Federation, 404120
    Completed
    Site DE49001
    Frankfurt am Main, Germany, 60596
    Completed
    Site GB44003
    Leeds, United Kingdom, LS7 9TF
    Completed
    Site BE32007
    Brussels, Brussels Hoofdstedelijk Gewest, Belgium, 1090
    Completed
    Site IT39015
    Ancona, Italy, 60126
    Completed
    Site IT39011
    Vicenza, Italy, 36100
    Completed
    Site ES34013
    Madrid, Spain, 28034
    Suspended
    Site PL48006
    Katowice, Poland, 40 027
    Completed
    Site DE49014
    Halle, Germany, 6120
    Completed
    Site CZ42003
    Olomouc, Czech Republic, 775 00
    Completed
    Site BE32001
    Gent, Belgium, 9000
    Completed
    Site KR82005
    Seoul, Republic of Korea, 110-744
    Completed
    Site BE32003
    Leuven, Belgium, 3000
    Completed
    Site DE49030
    Essen, Germany, 45147
    Completed
    Site IT39017
    Salerno, Italy, 84131
    Completed
    Site ES34021
    Valencia, Spain, 46009
    Completed
    Site AT43002
    Vienna, Austria, 1090
    Completed
    Site ES34016
    Valladolid, Spain, 47011
    Completed
    Site FI35801
    Helsinki, Finland, 00029
    Completed
    Site KR82002
    Seoul, Republic of Korea, 05505
    Completed
    Site ES34007
    Zaragoza, Spain, 50009
    Completed
    Site DE49015
    Kaiserslautern, Germany, 67655
    Completed
    Site FR33019
    Paris Cedex 20, France, 75970
    Completed
    Site SE46004
    Uppsala, Sweden, 75185
    Completed
    Site BE32008
    Liege, Belgium, 4000
    Completed
    Site RO40001
    Bucharest, Romania, 22328
    Completed
    Site FR33012
    Bordeaux, France, 33076
    Completed
    Site FR33014
    Montpellier Cedex 05, France, 34295
    Completed
    Site CZ42006
    Brno, Czech Republic, 65691
    Completed
    Site IT39005
    Bologna, Italy, 40138
    Completed
    Site HU36001
    Budapest, Hungary, 1082
    Completed
    Site ES34003
    Barcelona, Spain, 08036
    Completed
    Site IT39016
    Palermo, Italy, 90127
    Completed
    Site IT39012
    Milan, Italy, 20132
    Completed
    Site IT39008
    Naples, Italy, 80131
    Completed
    Site FR33017
    Strasbourg, France, 67091
    Completed
    Site FR33025
    Brest, France, 29609
    Withdrawn
    Site TR90003
    Istanbul, Turkey
    Completed
    Site DE49017
    Rostock, Germany, 18057
    Completed
    Site KR82006
    Daegu, Republic of Korea, 700-721
    Completed
    Site ES34005
    A Coruna, Spain, 15006
    Completed
    Site FI35802
    Helsinki, Finland, 00029
    Completed
    Site NL31001
    Maastricht, Netherlands, 6229 HX
    Completed
    Site BE32002
    Brussels, Belgium, 1070
    Completed
    Site IT39010
    Padova, Italy, 35128
    Completed
    Site RU70010
    Omsk, Russian Federation, 644112
    Completed
    Site CH41002
    Bern, Switzerland, 3010
    Completed
    Site RU70005
    Moscow, Russian Federation, 119992
    Completed
    Site BE32005
    Leuven, Belgium, 3000
    Completed
    Site ES34015
    Madrid, Madrid, Spain, 28041
    Completed
    Site DE49008
    Jena, Germany, 07747
    Completed
    Site IT39003
    Bergamo, Italy, 24122
    Completed
    Site IT39001
    Udine, Italy, 33100
    Completed
    Site IT39006
    Genova, Italy, 16132
    Completed
    Site ES34012
    Badalona-Barcelona, Spain, 8916
    Completed
    Site CA15001
    Halifax, NS, Canada, B3H2Y9
    Completed
    Site IT39002
    Padova, Italy, 35127
    Completed
    Site BY37501
    Minsk, Belarus, 220116
    Completed
    Site KR82001
    Seoul, Republic of Korea, 120-752
    Completed
    Site FR33004
    Nice Cedex 3, France, France, 06202
    Completed
    Site DE49013
    Dusseldorf, Germany, 40225
    Completed
    Site IT39020
    Rome, Italy, 00168
    Completed
    Site FR33022
    Saint Etienne, France, 42055
    Completed
    Site DE49010
    Regensburg, Germany, 93042
    Completed
    Site AT43001
    Innsbruck, Austria, 6020
    Completed
    Site ES34018
    Hospitalet de Llobregat, Spain, 08907
    Completed
    Site RU70014
    Kemerovo, Russian Federation, 650066
    Completed
    Site ES34010
    Cordoba, Spain, 14004
    Completed
    Site DE49002
    Kiel, Germany, 24105
    Completed
    Site ES34011
    Barcelona, Spain, 08035
    Completed
    Site RU70002
    Moscow, Russian Federation, 129090
    Completed
    Site DE49022
    Hannoversch Munden, Germany, 34346
    Completed
    Site FR33028
    Vandoeuvre les Nancy, France, 54511
    Completed
    Site DE49004
    Berlin, Germany, 13353
    Completed
    Site FR33034
    Toulouse Cedex 4, France, 31403
    Completed
    Site HU36003
    Debrecen, Hungary, 4012
    Completed
    Site FR33007
    Besancon, France, 25030
    Completed
    Site ES34009
    Tenerife, Tenerife, Spain, 38320
    Completed
    Site RU70007
    Moscow, Russian Federation, 129110
    Completed
    Site RU70012
    Ekaterinburg, Russian Federation, 620102
    Completed
    Site FR33018
    Limoges Cedex 1, France, 87042
    Completed
    Site ES34006
    Madrid, Spain, 28034
    Completed
    Site ES34019
    Barakaldo, Vizcaya, Spain, 48903
    Completed
    Site CZ42002
    Prague 4, Czech Republic, 140 21
    Completed
    Site PL48001
    Warsaw, Poland, 02-097
    Completed
    Site CZ42005
    Ostrava, Czech Republic, 70852
    Completed
    Site FR33020
    Angers Cedex 09, France, 49933
    Completed
    Site EE37201
    Tartu, Estonia, 51014
    Completed
    Site IE35301
    Dublin, Ireland, 4
    Completed
    Site FR33029
    Creteil, France, 94010
    Completed
    Site FR33002
    Villejuif, France, 94804
    Completed
    Site CZ42001
    Prague 4, Czech Republic, 140 21
    Completed
    Site AT43003
    Linz, Austria, 4010
    Completed
    Site IT39019
    Siena, Italy, 53100
    Completed
    Site FR33030
    Tours Cedex, France, 37044
    Completed
    Site PL48003
    Gdansk, Poland, 80211
    Completed
    Site KR82007
    Busan, Republic of Korea, 614-735
    Completed
    Site IT39009
    Milan, Italy, 20162
    Completed
    Site FR33011
    Marseille Cedex 05, France, 13385
    Completed
    Site GB44002
    London, United Kingdom, SE5 9RS
    Completed
    Site FR33015
    Nice Cedex 1, France, 6002
    Completed
    Site ES34020
    Santander, Spain, 39008
    Completed
    Site FR33009
    Tours, France, 37044
    Completed
    Site IT39021
    Treviso, Italy, 31100
    Completed
    Site ES34017
    Alicante, Spain, 03010
    Completed
    Site FR33023
    Nantes Cedex 01, France, 44093
    Completed
    Site FR33010
    Paris cedex 13, France, 75651
    Completed
    Site GB44001
    Birmingham, United Kingdom, B15 2TH
    Completed
    Site IT39014
    L'Aquila, Italy, 67100
    Completed
    Site IT39004
    Rome, Italy, 00133
    Completed
    Site PT35102
    Lisbon, Portugal, 1069-166
    Completed
    Site DE49005
    Hannover, Germany, 30625
    Completed
    Site DE49011
    Aachen, Germany, 52074
    Completed
    Site DE49025
    Munich, Germany, 81377
    Completed
    Site DE49016
    Munich, Germany, 81675
    Completed
    Site PL48007
    Poznan, Poland, 60-479

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?